GF-107

N/A

Report date: 2026/04/29 20:02:18
NME

Base Information

Drug NameGF-107
Drug Alias NameGF-107GFH312
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsAutoimmune DiseasesIntermittent ClaudicationPeripheral Arterial Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGenfleet Therapeutics (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGenFleet Therapeutics (Australia) Pty LtdZhejiang Genfleet Therapeutics Co LtdGenfleet Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesCholangitis, SclerosingCholangitis +[4] 
Inactive IndicationsIntermittent ClaudicationPeripheral Arterial Disease

Other Information

ATC CodeN/A
Related LinksN/A